References
Kitada, T., DiAndreth, B., Teague, B., & Weiss, R. (2018). Programming gene and engineered-cell therapies with synthetic biology. Science (New York, N.Y.), 359(6376), eaad1067. https://doi.org/10.1126/science.aad1067 
Nakamura, K., & Matsunaga, K. (1998). Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD). Cancer biotherapy & radiopharmaceuticals, 13(4), 275–290. https://doi.org/10.1089/cbr.1998.13.275 
Nauseef W. M. (2014). Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases. Biochimica et biophysica acta, 1840(2), 757–767. https://doi.org/10.1016/j.bbagen.2013.04.040 
Tong, L., Jiménez-Cortegana, C., Tay, A. H. M., Wickström, S., Galluzzi, L., & Lundqvist, A. (2022). NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular cancer, 21(1), 206. https://doi.org/10.1186/s12943-022-01672-z 
Wu, SY., Fu, T., Jiang, YZ. et al. Natural killer cells in cancer biology and therapy. Mol Cancer 19, 120 (2020). https://doi.org/10.1186/s12943-020-01238-x 
Yang, Y., Neo, S. Y., Chen, Z., Cui, W., Chen, Y., Guo, M., Wang, Y., Xu, H., Kurzay, A., Alici, E., Holmgren, L., Haglund, F., Wang, K., & Lundqvist, A. (2020). Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells. The Journal of clinical investigation, 130(10), 5508–5522. https://doi.org/10.1172/JCI137585 
